SCHEMBL14282249

SCHEMBL14282249

CCOC(=O)N1CC=C(c2cccc(C(F)(F)F)c2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.51
PPARG P37231 1/20 0.51
PPARA Q07869 1/20 0.51
MAPT P10636 2/20 0.49
KDM4E B2RXH2 1/20 0.49
TDP1 Q9NUW8 1/20 0.49
CCR2 P41597 1/20 0.49
GRM5 P41594 1/20 0.48
ALOX15 P16050 1/20 0.48
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
SOS1 Q07889 1/20 0.46
TRPV1 Q8NER1 1/20 0.46
HPGD P15428 1/20 0.45
HTT P42858 1/20 0.45
NPC1 O15118 1/20 0.45
RAB9A P51151 1/20 0.45
ELANE P08246 1/20 0.45
XPO1 O14980 1/20 0.44
HTR2C P28335 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2807104 0.83 ALDH1A1 (0.58) ALDH1A1MAPTKDM4ETDP1ALOX15
Hydrochloric Acid SCHEMBL10734951 0.83 MEN1 (0.53) PPARGPPARATDP1CCR2MEN1
SCHEMBL2930491 0.83 CCR2 (0.51) ALDH1A1PPARGPPARAMAPTKDM4E
SCHEMBL1760912 0.82 CCR2 (0.50) ALDH1A1PPARGPPARAMAPTCCR2
SCHEMBL187309 0.81 MEN1 (0.50) ALDH1A1PPARGPPARAMAPTTDP1
SCHEMBL10738116 0.79 CCR2 (0.52) ALDH1A1MAPTKDM4ECCR2ALOX15
SCHEMBL10972353 0.79 PPARG (0.52) PPARGPPARAMAPTKDM4ECCR2
SCHEMBL1274660 0.78 PDK4 (0.51) ALDH1A1MAPTKDM4ETDP1GRM5
Hydrochloric Acid SCHEMBL10736189 0.78 PPARG (0.51) PPARGPPARAMAPTKDM4ECCR2
SCHEMBL10638336 0.78 HTR2C (0.54) PPARGPPARAHTR2C

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080015225-A1 Dimeric Piperidine Derivatives JANSSEN PHARMACEUTICA N.V. (BE) 2008-01-17 US disclosed
US-20080015225-A1 Dimeric Piperidine Derivatives JANSSEN PHARMACEUTICA N.V. (BE) 2008-01-17 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080015225-A1 Dimeric Piperidine Derivatives PTGER4, PTGER3, PTGER1 ALDH1A1 646/4885PPARG 810/4885PPARA 614/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.